Rofecoxib and Cardiovascular Adverse Events in Adjuvant Treatment … - New England Journal of Medicine (subscription)
Rofecoxib and Cardiovascular Adverse Events in Adjuvant Treatment …New England Journal of Medicine (subscription), MA - 3 hours agoInclusion criteria were as follows: histologically proven colorectal carcinoma of stage III (any tumor stage, N1 or 2, and M0) or stage II (T3 or 4, N0, …
Read full story